The US administration’s TrumpRx initiative and a proposed Medicare incentive rule link drug pricing, tariff policy, and domestic manufacturing in a coordinated push to reshore pharmaceutical production, highlighting shifting industry priorities, says GlobalData, a leading intelligence and productivity platform. Launched in February 2026, TrumpRx enables cash-paying and uninsured patients to access selected branded medicines at […]

Model Medicines presented an update on its lead candidate MDL-001 at the Biocom Global Partnering Conference in California, positioning the asset as a first-in-class oral direct-acting antiviral with demonstrated preclinical activity across various viral families, including respiratory, hepatic, and gastrointestinal viruses. With such a broad therapeutic spectrum, MDL-001 has potential to address unmet needs including […]